Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922K Buy
3,665
+232
+7% +$49.9K 0.17% 119
2026
Q1
$738K Buy
3,433
+1,584
+86% +$351K 0.15% 129
2025
Q4
$422K Buy
1,849
+545
+42% +$124K 0.13% 137
2025
Q3
$319K Buy
1,304
+399
+44% +$81.3K 0.1% 188
2025
Q2
$168K Sell
905
-127
-12% -$23.6K 0.06% 282
2025
Q1
$192K Sell
1,032
-327
-24% -$63.6K 0.08% 230
2024
Q4
$241K Buy
+1,359
New +$250K 0.15% 156

Other funds holding ABBV

Rossby Financial's ABBV Position: Q2 2026 in Review

Rossby Financial increased its AbbVie (ABBV) stake by 6.8% in Q2 2026, buying an estimated $49.9K and bringing the position to 3,665 shares worth $922K. The position accounts for 0.17% of the portfolio, ranked #119.

Rossby Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rossby Financial held 3,665 shares of AbbVie worth $922K as of Q2 2026.
  • Rossby Financial bought 232 AbbVie shares in Q2 2026, an estimated $49.9K.
  • AbbVie made up 0.17% of Rossby Financial's portfolio in Q2 2026, its #119 holding.
  • Rossby Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.